1. Home
  2. LNZA vs NKTR Comparison

LNZA vs NKTR Comparison

Compare LNZA & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNZA
  • NKTR
  • Stock Information
  • Founded
  • LNZA 2005
  • NKTR 1990
  • Country
  • LNZA United States
  • NKTR United States
  • Employees
  • LNZA N/A
  • NKTR N/A
  • Industry
  • LNZA Major Chemicals
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNZA Industrials
  • NKTR Health Care
  • Exchange
  • LNZA Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • LNZA 199.8M
  • NKTR 160.4M
  • IPO Year
  • LNZA N/A
  • NKTR 1994
  • Fundamental
  • Price
  • LNZA $0.20
  • NKTR $0.78
  • Analyst Decision
  • LNZA Hold
  • NKTR Strong Buy
  • Analyst Count
  • LNZA 2
  • NKTR 6
  • Target Price
  • LNZA $2.00
  • NKTR $4.92
  • AVG Volume (30 Days)
  • LNZA 4.7M
  • NKTR 2.8M
  • Earning Date
  • LNZA 04-15-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • LNZA N/A
  • NKTR N/A
  • EPS Growth
  • LNZA N/A
  • NKTR N/A
  • EPS
  • LNZA N/A
  • NKTR N/A
  • Revenue
  • LNZA $49,592,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • LNZA $122.29
  • NKTR N/A
  • Revenue Next Year
  • LNZA $21.36
  • NKTR N/A
  • P/E Ratio
  • LNZA N/A
  • NKTR N/A
  • Revenue Growth
  • LNZA N/A
  • NKTR 9.21
  • 52 Week Low
  • LNZA $0.14
  • NKTR $0.43
  • 52 Week High
  • LNZA $3.26
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • LNZA 37.18
  • NKTR 59.90
  • Support Level
  • LNZA $0.15
  • NKTR $0.43
  • Resistance Level
  • LNZA $0.31
  • NKTR $0.68
  • Average True Range (ATR)
  • LNZA 0.04
  • NKTR 0.07
  • MACD
  • LNZA 0.02
  • NKTR 0.03
  • Stochastic Oscillator
  • LNZA 31.01
  • NKTR 90.84

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: